► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Activist investor Dan Loeb wants the biotechnology company Amgen to think about splitting into two. Lex's Oliver Ralph and Robert Armstrong discuss why splits are advocated and whether it would work in Amgen's case.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
